Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Ramona develops high-throughput microscopy tools to unlock previously impossible experiments within the modern biology lab.
Mindstrong is a virtual mental health platform.
AgBiome discovers and develops innovative biological and trait products for crop protection.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Happy Health is a mission-driven technology company
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Oratomic develops neutral-atom quantum hardware and error-correction architectures for utility-scale fault-tolerant quantum computers.
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Dispatch Biotherapeutics develops immunotherapy that treats solid tumors, which could significantly advance cancer treatment options.
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
ARCH Venture Partners has invested in 239 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 28 different industry categories.
Among tracked funding rounds, Altos Labs received $3.0B in a Series A round. ARCH Venture Partners's total known invested capital is $28.2B.
ARCH Venture Partners's average investment size is $150.7M across its portfolio of 239 companies.
Recent ARCH Venture Partners portfolio additions include Encoded Therapeutics, Rapport Therapeutics, Moonwalk Biosciences, Altos Labs, EGenesis. These companies were founded in 2020 or later.